Prof. Michael K. Stehling is an acknowledged expert in the diagnosis and treatment of prostatic conditions. As its Director, Prof. Stehling has led the Prostate Centre he founded in Offenbach, which specialises in the most advanced diagnosis and minimally invasive treatment techniques for cancer of the prostate and other prostatic conditions, since 2010. The Prostate Centre in Offenbach is a world leader in the field of IRE / NanoKnife® treatment for prostatic cancer.
Specialists in a wide variety of fields, including physicists, as well as specialists in urology, radiology, radiotherapy, oncology and internal medicine, collaborate in an interdisciplinary fashion in the Prostate Centre in Offenbach. Hence, patients affected by prostatic conditions are given the optimal care from the one source. At the same time, the service portfolio of the Prostate Centre in Offenbach ranges from the most up-to-date biopsy-free prostate diagnosis techniques to personal, detailed and independent patient advice concerning all therapeutic options for prostatic cancer, and to the most advanced minimally invasive treatment techniques.
In the field of diagnostics, Prof. Stehling specialises in advanced MRI prostate diagnostics, in particular. Magnetic resonance imaging of the prostate enables a precise diagnosis to be made without an invasive procedure and without pain or exposure to radiation. Prof. Stehling was a scientific employee of Sir Peter Mansfield, who was awarded the Nobel Prize in 2003 for the development of magnetic resonance imaging. As one of the leading minds in the development of magnetic resonance imaging, Prof. Stehling is one of the most experienced experts in this field.
One particular treatment emphasis of Prof. Stehling and his team is so-called irreversible electroporation (IRE), also referred to as NanoKnife® treatment for short, for cancer of the prostate. Using this innovative treatment technique, side-effects such as impotence or incontinence, which frequently occur with conventional prostate treatments, can be prevented in most cases. Over the last 5 years, under the leadership of Prof. Stehling, the Prostate Centre has been the world leader in the development of the NanoKnife® technique for operational use in the treatment of prostatic cancer.
Other treatment techniques which are used by Prof. Stehling and his team of experts at the Prostate Centre in Offenbach are so-called electrochemotherapy (ECT), immunotherapy, radiotherapy using the CyberKnife and high-intensity focused ultrasound (HIFU).
MRI (magnetic resonance imaging) of the prostate
Whole-body MRI (staging, metastases etc.)
MRI-planned biopsy of the prostate
3-D saturation biopsy of the prostate
Irreversible electroporation (IRE / NanoKnife) of the prostate
Electrochemotherapy (ECT), for example, for boney and lymph node metastases
Medication-based treatment and immunotherapy for metastasising prostatic cancer
Many other treatment options for early and advanced prostatic carcinoma
of selected experts in the specialist field Prostate Cancer